Abstract
Background
Craniopharyngiomas are uncommon benign sellar and parasellar tumors with high overall survival (OS) and recurrence rates. Treatment is often surgical but may include adjuvant therapies. The impact of adjuvant therapy and surgical approach have been evaluated, however, facility volume and type have not. The purpose of this study is to analyze the influence of facility volume and type on treatment modalities, extent of surgery and survival of craniopharyngioma.
Methods
The 2004–2016 National Cancer Database (NCDB) was queried for patients diagnosed with craniopharyngioma. Facilities were classified by type (academic vs. non-academic) and low-volume center (LVC) (Treating < 8 patients over the timeline) versus high-volume center (HVC), (Treating ≥ 8 patients over the timeline). Differences in treatment course, outcomes, and OS by facility type were assessed.
Results
3730 patients (51.3% female) with mean age 41.2 ± 22.0 were included with a 5-year estimated OS of 94.8% (94.0–95.5%). 2564 (68.7%) patients were treated at HVC, of which 2142 (83.5%) were treated at academic facilities. Patients treated at HVC’s were more likely to undergo both surgery and radiation. Surgical approach at HVC was more likely to be endoscopic. Patients treated at HVC demonstrated significantly higher 5-year OS compared to patients treated at LVC (96% [95% CI 95.6–97.1% versus 91.2% [95% CI 89–92.7%] with lower risk of mortality (Hazard ratio [95% CI] = 0.69 [0.56–0.84]).
Conclusion
Treatment of craniopharyngioma at HVC compared to LVC is associated with improved OS, lower 30- and 90-day postoperative mortality risk, and more common use of both radiotherapy and endoscopic surgical approach.
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.
References
Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S (2019) Craniopharyngioma. Nat Rev Dis Primer 5(1):75. https://doi.org/10.1038/s41572-019-0125-9
Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89(4):547–551. https://doi.org/10.3171/jns.1998.89.4.0547
Nielsen EH, Feldt-Rasmussen U, Poulsgaard L et al (2011) Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol 104(3):755–763. https://doi.org/10.1007/s11060-011-0540-6
Hill TK, Baine MJ, Verma V et al (2019) Patterns of care in pediatric craniopharyngioma: outcomes following definitive radiotherapy. Anticancer Res 39(2):803–807. https://doi.org/10.21873/anticanres.13178
Rao YJ, Hassanzadeh C, Fischer-Valuck B et al (2017) Patterns of care and treatment outcomes of patients with craniopharyngioma in the national cancer database. J Neurooncol 132(1):109–117. https://doi.org/10.1007/s11060-016-2342-3
Zhang C, Verma V, Lyden ER et al (2018) The Role of definitive radiotherapy in craniopharyngioma: a SEER analysis. Am J Clin Oncol 41(8):807–812. https://doi.org/10.1097/COC.0000000000000378
Pang JC, Chung D, Ovakimyan A et al (2022) Characteristics and Outcomes in pediatric versus adult craniopharyngiomas: a systematic review and meta-analysis. 31st Annu Meet North Am Skull Base Soc. https://doi.org/10.1055/s-0042-1743663
Olsson DS, Andersson E, Bryngelsson IL, Nilsson AG, Johannsson G (2015) Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. J Clin Endocrinol Metab 100(2):467–474. https://doi.org/10.1210/jc.2014-3525
Wijnen M, Olsson DS, van den Heuvel-Eibrink MM et al (2018) Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study. Eur J Endocrinol 178(1):93–102. https://doi.org/10.1530/EJE-17-0707
Lehrich BM, Goshtasbi K, Hsu FPK, Kuan EC (2021) Characteristics and overall survival in pediatric versus adult craniopharyngioma: a population-based study. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg. https://doi.org/10.1007/s00381-021-05094-y
Yang I, Sughrue ME, Rutkowski MJ et al (2010) Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus 28(4):E5. https://doi.org/10.3171/2010.1.FOCUS09307
Lin LL, El Naqa I, Leonard JR et al (2008) Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr 1(2):126–130. https://doi.org/10.3171/PED/2008/1/2/126
Goshtasbi K, Vasudev M, Torabi SJ et al (2021) The influence of facility volume and type on esthesioneuroblastoma treatment and outcomes. Int Forum Allergy Rhinol Published online. https://doi.org/10.1002/alr.22948
Goshtasbi K, Abiri A, Lehrich BM, Haidar YM, Tjoa T, Kuan EC (2021) The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma. Head Neck. https://doi.org/10.1002/hed.26739
Chen AY, Pavluck A, Halpern M, Ward E (2009) Impact of treating facilities’ volume on survival for early-stage laryngeal cancer. Head Neck 31(9):1137–1143. https://doi.org/10.1002/hed.21072
David JM, Ho AS, Luu M et al (2017) Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer. Cancer 123(20):3933–3942. https://doi.org/10.1002/cncr.30843
Bitner BF, Lehrich BM, Abiri A, Yasaka TM, Hsu FPK, Kuan EC (2021) Characteristics and overall survival in pediatric versus adult pituitary adenoma: a national cancer database analysis. Pituitary. https://doi.org/10.1007/s11102-021-01146-3
Sharma A, Schwartz SM, Méndez E (2013) Hospital volume is associated with survival but not multimodality therapy in medicare patients with advanced head and neck cancer. Cancer 119(10):1845–1852. https://doi.org/10.1002/cncr.27976
Chen AY, Fedewa S, Pavluck A, Ward EM (2010) Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer 116(20):4744–4752. https://doi.org/10.1002/cncr.25364
Gourin CG, Stewart CM, Frick KD et al (2019) Association of hospital volume with laryngectomy outcomes in patients with larynx cancer. JAMA Otolaryngol—Head Neck Surg 145(1):62–70. https://doi.org/10.1001/jamaoto.2018.2986
Yoshida EJ, Luu M, David JM et al (2018) Facility volume and survival in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 100(2):408–417. https://doi.org/10.1016/j.ijrobp.2017.09.038
Cheung MC, Koniaris LG, Perez EA, Molina MA, Goodwin WJ, Salloum RM (2009) Impact of hospital volume on surgical outcome for head and neck cancer. Ann Surg Oncol 16(4):1001–1009. https://doi.org/10.1245/s10434-008-0191-9
Roman KM, Torabi SJ, Bitner BF et al (2023) The impact of facility type and volume on outcomes in head and neck mucosal melanoma. Otolaryngol Neck Surg 168(5):1079–1088. https://doi.org/10.1002/ohn.173
Awad M, Butterfield JT, Dhawan S, Tyler MA, Venteicher AS (2023) Prognostic factors and treatment impact on overall survival in adult craniopharyngioma. World Neurosurg 173:e132–e139. https://doi.org/10.1016/j.wneu.2023.02.020
Liu APY, Tung JYL, Ku DTL et al (2020) Outcome of Chinese children with craniopharyngioma: a 20-year population-based study by the Hong Kong Pediatric Hematology/Oncology Study Group. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 36(3):497–505. https://doi.org/10.1007/s00381-019-04480-x
Ouyang D, El-Sayed IH, Yom SS (2014) National trends in surgery for sinonasal malignancy and the effect of hospital volume on short-term outcomes. Laryngoscope 124(7):1609–1614. https://doi.org/10.1002/lary.24578
Teitelbaum JI, Issa K, Barak IR et al (2020) Sinonasal squamous cell carcinoma outcomes: does treatment at a high-volume center confer survival benefit? Otolaryngol - Head Neck Surg U S 163(5):986–991. https://doi.org/10.1177/0194599820935395
Abiri A, Roman KM, Latif K et al (2022) Endoscopic versus Nonendoscopic surgery for resection of craniopharyngiomas. World Neurosurg. https://doi.org/10.1016/j.wneu.2022.08.068
Li X, Wu W, Miao Q et al (2019) Endocrine and metabolic outcomes after transcranial and endoscopic endonasal approaches for primary resection of craniopharyngiomas. World Neurosurg 121:e8–e14. https://doi.org/10.1016/j.wneu.2018.08.092
Komotar RJ, Starke RM, Raper DMS, Anand VK, Schwartz TH (2012) Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of craniopharyngiomas. World Neurosurg 77(2):329–341. https://doi.org/10.1016/j.wneu.2011.07.011
Mortini P, Losa M, Pozzobon G et al (2011) Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series: clinical article. J Neurosurg 114(5):1350–1359. https://doi.org/10.3171/2010.11.JNS10670
Mesman R, Westert GP, Berden BJMM, Faber MJ (2015) Why do high-volume hospitals achieve better outcomes? a systematic review about intermediate factors in volume-outcome relationships. Health Policy Amst Neth 119(8):1055–1067. https://doi.org/10.1016/j.healthpol.2015.04.005
PDQ Pediatric Treatment Editorial Board. Childhood Craniopharyngioma Treatment (PDQ®): Health Professional Version. In: PDQ Cancer Information Summaries. National Cancer Institute (US); 2002. http://www.ncbi.nlm.nih.gov/books/NBK65891/. Accessed 22 May 2023
Zhu P, Du XL, Blanco AI et al (2020) Impact of facility type and volume in low-grade glioma outcomes. J Neurosurg 133(5):1313–1323. https://doi.org/10.3171/2019.6.JNS19409
Jimenez RB, Ahmed S, Johnson A et al (2021) Proton radiation therapy for pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys 110(5):1480–1487. https://doi.org/10.1016/j.ijrobp.2021.02.045
Drapeau A, Walz PC, Eide JG et al (2019) Pediatric craniopharyngioma. Childs Nerv Syst 35(11):2133–2145. https://doi.org/10.1007/s00381-019-04300-2
Schoonbeek RC, Zwertbroek J, Plaat BEC et al (2021) Determinants of delay and association with outcome in head and neck cancer: a systematic review. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 47(8):1816–1827. https://doi.org/10.1016/j.ejso.2021.02.029
Ortiz Torres M, Shafiq I, Mesfin FB. Craniopharyngioma. In: StatPearls. StatPearls Publishing; 2023. http://www.ncbi.nlm.nih.gov/books/NBK459371/. Accessed 22 May 2023
Naghavi AO, Echevarria MI, Strom TJ et al (2018) Patient choice for high-volume center radiation impacts head and neck cancer outcome. Cancer Med 7(10):4964–4979. https://doi.org/10.1002/cam4.1756
Du AT, Pang JC, Victor R et al (2022) The influence of facility volume and type on skull base chordoma treatment and outcomes. World Neurosurg 166:e561–e567. https://doi.org/10.1016/j.wneu.2022.07.064
Zoicas F, Schöfl C (2012) Craniopharyngioma in adults. Front Endocrinol. https://doi.org/10.3389/fendo.2012.00046
Shiminski-Maher T, Rosenberg M (1990) Late effects associated with treatment of craniopharyngiomas in childhood. J Neurosci Nurs 22(4):220–226. https://doi.org/10.1097/01376517-199008000-00006
Park HJ, Dho YS, Kim JH, Kim JW, Park CK, Kim YH (2020) Recurrence rate and prognostic factors for the adult craniopharyngiomas in long-term follow-Up. World Neurosurg 133:e211–e217. https://doi.org/10.1016/j.wneu.2019.08.209
Goshtasbi K, Lehrich BM, Abouzari M et al (2020) Endoscopic versus nonendoscopic surgery for resection of pituitary adenomas: a national database study. J Neurosurg 134(3):816–824. https://doi.org/10.3171/2020.1.JNS193062
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Contributions
BFB: Conceptualization, methodology, writing—original drafting, writing—review & editing, approval of final version. DHL: Conceptualization, methodology, statistical analysis, writing—original drafting, writing—review & editing, approval of final version. MMN: Conceptualization, writing—original drafting, writing—review & editing, approval of final version. SJT: Conceptualization, methodology, writing—original drafting, writing—review & editing, approval of final version. FPKH: Scientificc advisor, approval of final version. ECK: Conceptualization, methodology, writing—original drafting, writing—review & editing, supervision, approval of final version.
Corresponding author
Ethics declarations
Competing interests
The authors have no conflicts of interest to declare that are relevant to this article.
Ethical approval
The study was exempt from review by the University of California, Irvine Institutional Review Board given the publicly available, de-identified nature of the NCDB.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
A portion of this work was presented as a podium presentation for the North American Skull Base Society at the NASBS 31st Annual Meeting, February 19, 2022.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bitner, B.F., Liu, D.H., Nottoli, M.M. et al. The impact of facility type and volume on treatment and overall survival in craniopharyngioma. Pituitary 26, 686–695 (2023). https://doi.org/10.1007/s11102-023-01359-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-023-01359-8